APA

Pui C., Pei D., Coustan-Smith E., Jeha S., Cheng C., Bowman W. P., Sandlund J. T., Ribeiro R. C., Rubnitz J. E., Inaba H., Bhojwani D., Gruber T. A., Leung W. H., Downing J. R., Evans W. E., Relling M. V. & Campana D. (20150629). Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. : The Lancet. Oncology.

Chicago

Pui Ching-Hon, Pei Deqing, Coustan-Smith Elaine, Jeha Sima, Cheng Cheng, Bowman W Paul, Sandlund John T, Ribeiro Raul C, Rubnitz Jeffrey E, Inaba Hiroto, Bhojwani Deepa, Gruber Tanja A, Leung Wing H, Downing James R, Evans William E, Relling Mary V and Campana Dario. 20150629. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. : The Lancet. Oncology.

Harvard

Pui C., Pei D., Coustan-Smith E., Jeha S., Cheng C., Bowman W. P., Sandlund J. T., Ribeiro R. C., Rubnitz J. E., Inaba H., Bhojwani D., Gruber T. A., Leung W. H., Downing J. R., Evans W. E., Relling M. V. and Campana D. (20150629). Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. : The Lancet. Oncology.

MLA

Pui Ching-Hon, Pei Deqing, Coustan-Smith Elaine, Jeha Sima, Cheng Cheng, Bowman W Paul, Sandlund John T, Ribeiro Raul C, Rubnitz Jeffrey E, Inaba Hiroto, Bhojwani Deepa, Gruber Tanja A, Leung Wing H, Downing James R, Evans William E, Relling Mary V and Campana Dario. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. : The Lancet. Oncology. 20150629.